These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10642059)

  • 1. Treatment of cutaneous leishmaniasis with 20% paromomycin ointment.
    Stanimirović A; Stipić T; Skerlev M; Basta-Juzbasić A
    J Eur Acad Dermatol Venereol; 1999 Nov; 13(3):214-7. PubMed ID: 10642059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of Iran.
    Asilian A; Jalayer T; Nilforooshzadeh M; Ghassemi RL; Peto R; Wayling S; Olliaro P; Modabber F
    Bull World Health Organ; 2003; 81(5):353-9. PubMed ID: 12856053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous leishmaniasis due to Leishmania infantum. Case reports and literature review.
    del Giudice P; Marty P; Lacour JP; Perrin C; Pratlong F; Haas H; Dellamonica P; Le Fichoux Y
    Arch Dermatol; 1998 Feb; 134(2):193-8. PubMed ID: 9487211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous leishmaniasis treatment.
    Minodier P; Parola P
    Travel Med Infect Dis; 2007 May; 5(3):150-8. PubMed ID: 17448941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, placebo-controlled trial of a two-week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran.
    Asilian A; Jalayer T; Whitworth JA; Ghasemi RL; Nilforooshzadeh M; Olliaro P
    Am J Trop Med Hyg; 1995 Dec; 53(6):648-51. PubMed ID: 8561269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis.
    Moosavi Z; Nakhli A; Rassaii S
    Int J Dermatol; 2005 Dec; 44(12):1064-5. PubMed ID: 16409282
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful Treatment of Cutaneous Leishmaniasis with Topical Paramomycin in a Child After Treatment Failure with Systemic Fluconazole.
    Chacko A; Joseph M; Feltis T; Morris SK
    Am J Trop Med Hyg; 2016 Oct; 95(4):793-794. PubMed ID: 27549634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of topical paromomycin sulfate (twice/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major.
    Shazad B; Abbaszadeh B; Khamesipour A
    Eur J Dermatol; 2005; 15(2):85-7. PubMed ID: 15757817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Successful topical treatment of chronic cutaneous leishmaniasis with paromomycin sulfate (15%) and methylbenzethonium chloride (12%)].
    Schallreuter KU; Lemke KR
    Hautarzt; 1994 Nov; 45(11):783-6. PubMed ID: 7822205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin.
    Grogl M; Schuster BG; Ellis WY; Berman JD
    J Parasitol; 1999 Apr; 85(2):354-9. PubMed ID: 10219319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-ulcerative cutaneous leishmaniasis in Honduras fails to respond to topical paromomycin.
    Neva FA; Ponce C; Ponce E; Kreutzer R; Modabber F; Olliaro P
    Trans R Soc Trop Med Hyg; 1997; 91(4):473-5. PubMed ID: 9373659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical 15% Paromomycin-Aquaphilic for Bolivian Leishmania braziliensis Cutaneous Leishmaniasis: A Randomized, Placebo-controlled Trial.
    Soto J; Soto P; Ajata A; Luque C; Tintaya C; Paz D; Rivero D; Berman J
    Clin Infect Dis; 2019 Feb; 68(5):844-849. PubMed ID: 30260376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous Leishmaniasis in an American Adolescent Returning From Israel.
    Ganjaei KG; Lawton K; Gaur S
    J Pediatric Infect Dis Soc; 2018 Aug; 7(3):e178-e181. PubMed ID: 29878238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occlusive paromomycin for cutaneous leishmaniasis.
    Bell SA; Schaller M; Röcken M
    Lancet; 1997 Jan; 349(9044):29. PubMed ID: 8988124
    [No Abstract]   [Full Text] [Related]  

  • 15. Aminosidine ointments for the treatment of experimental cutaneous leishmaniasis.
    Neal RA; Murphy AG; Olliaro P; Croft SL
    Trans R Soc Trop Med Hyg; 1994; 88(2):223-5. PubMed ID: 8036682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cutaneous leishmaniasis].
    Enk CD; Gardlo K; Hochberg M; Ingber A; Ruzicka T
    Hautarzt; 2003 Jun; 54(6):506-12. PubMed ID: 12759734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmania tropica in children: a retrospective study.
    Solomon M; Schwartz E; Pavlotsky F; Sakka N; Barzilai A; Greenberger S
    J Am Acad Dermatol; 2014 Aug; 71(2):271-7. PubMed ID: 24775403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reductions in skin and systemic parasite burdens as a combined effect of topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) amazonensis.
    Aguiar MG; Pereira AM; Fernandes AP; Ferreira LA
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4699-704. PubMed ID: 20713665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occlusive paromomycin for cutaneous leishmaniasis.
    Bryceson AD
    Lancet; 1997 May; 349(9063):1477. PubMed ID: 9164342
    [No Abstract]   [Full Text] [Related]  

  • 20. Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 2.
    Zur E
    Int J Pharm Compd; 2019; 23(4):288-293. PubMed ID: 31315079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.